Wordt geladen...
Protective effect of sodium–glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease and type 2 diabetes
AIMS/INTRODUCTION: The risk of end‐stage kidney disease increases in proportion to the decline in the estimated glomerular filtration rate (eGFR). Although protective effects of sodium–glucose cotransporter 2 inhibitors (SGLT2i) on the eGFR decline were shown in several large‐scale clinical trials,...
Bewaard in:
| Gepubliceerd in: | J Diabetes Investig |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6825940/ https://ncbi.nlm.nih.gov/pubmed/31026373 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13064 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|